Skip to main content
Premium Trial:

Request an Annual Quote

LifeMark to Offer Cancer Genomic Profiling Service to Life Insurance Customers

NEW YORK (GenomeWeb) – Insurance marketing organization LifeMark Partners announced today that its affiliate brokerage general agents (BGAs) will now offer Wamberg Genomic Advisors' Cancer Guardian genomic profiling program to new and existing life insurance clients.

Cancer Guardian is a personalized medicine program under which customers who develop cancer are provided tumor sequencing and analysis services at no cost to assist in their treatment.

According to LifeMark, its partner BGAs will initially provide 250,000 individuals who purchase new life insurance policies complimentary one-year access to the Cancer Guardian program. Additionally, 2 million existing policy holders who have purchased life insurance through LifeMark and its affiliated BGAs will be offered a discount to the program.

"This progressive program is a vital tool that will allow our partners to help clients of their advisors, producers, and agents should they suffer the unfortunate diagnosis of cancer," LifeMark President and CEO William Shelow said in a statement.